This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency

This study has been completed.
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nīmes Identifier:
First received: April 8, 2010
Last updated: December 17, 2015
Last verified: December 2015
Dialysis catheters are sites of bacterial proliferation. The purpose of this study is to determine whether or not the use of Taurolock (a catheter lock solution) can prevent bacterial peritonitis in patients undergoing peritoneal dialysis.

Condition Intervention
Peritonitis Catheter-related Infections Renal Insufficiency Device: Taurolock Other: Placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Prevention
Official Title: Efficacity of Taurolock in Preventing Primary Bacterial Peritonitis in Patients Undergoing Peritoneal Dialysis for Renal Insufficiency: a Randomized, Multicenter, Double Blind Study With Placebo

Further study details as provided by Centre Hospitalier Universitaire de Nīmes:

Primary Outcome Measures:
  • Occurence of bacterial peritonitis [ Time Frame: 24 months ]

Enrollment: 150
Study Start Date: July 2010
Study Completion Date: December 2015
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Taurolock Device: Taurolock
Placebo Comparator: Placebo Other: Placebo
Injectable sodium chloride conditioned in exactly the same manner as the experimental product.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 years or older
  • Renal insufficiency, stage V (HAS 2007 classification)
  • Requires incident peritoneal dialysis
  • No signs of peritoneal infection on inclusion
  • signed consent
  • affiliated with a social security system

Exclusion Criteria:

  • Patient will have a renal transplant in the upcoming year following dialysis
  • Survival prognosis for one year is weak
  • allergy to citrate, (cyclo)-taurolidine, or heparin
  • patient is taking medication with a known contra-indication with citrate or (cyclo)-taurolidine
  • patient has a thrombopenia caused by heparin
  • impossible to inform the patient correctly
  • patient under guardianship
  • patient already included in another biomedical research protocol
  • no signed consent
  • no social security system
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01101087

CHU de Nîmes - Hôpital Universitaire Carémeau
Nimes, Gard, France, 30029
CH d'Avignon - Centre Hospitalier Henri Duffaut
Avignon, France, 84902
CHU de Caen - Hôpital Clemenceau
Caen, France, 14033
CH de Chambéry
Chambery, France, 73011
CH de Colmar - Hôpitaux Civils de Colmar
Colmar, France, 68024
Association CALYDIAL Vienne
Irigny, France, 69540
Centre Hospitalier Départemental Vendée - Site de la Roche sur Yon
La Roche sur Yon, France, 85925
AIDER - Clinque Jacques Mirouze
Montpellier, France, 34295
APHP - Groupe Hospitalier Pitié-Salpetrière
Paris, France, 75651
CH Pontoise - Centre Hospitalier René Dubos
Pontoise, France, 95300
Association AUB Santé Quimper
Quimper, France, 29000
Centre Hospitalier Regional - Site Groupe Hospitalier Sud Réunion (GHSR)
Saint Pierre, France, 97448
CH de Valenciennes - Hôpital Jean Bernard et Hôtel Dieu
Valenciennes, France, 59322
ALTIR - Hôpital Brabois
Vandoeuvre les Nancy Cedex, France, 54504
French Polynesia
Association APURAD
Paéa, French Polynesia, 98711
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nīmes
Principal Investigator: Bernard Branger, MD Centre Hospitalier Universitaire de Nîmes
  More Information

Responsible Party: Centre Hospitalier Universitaire de Nīmes Identifier: NCT01101087     History of Changes
Other Study ID Numbers: PHRC-N/2009/BB
2009-A00599-48 ( Other Identifier: RCB number )
Study First Received: April 8, 2010
Last Updated: December 17, 2015

Keywords provided by Centre Hospitalier Universitaire de Nīmes:

Additional relevant MeSH terms:
Renal Insufficiency
Catheter-Related Infections
Kidney Diseases
Urologic Diseases
Intraabdominal Infections
Peritoneal Diseases
Digestive System Diseases processed this record on September 21, 2017